Böhl-Iggelheim, Germany

Dieter Flick

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dieter Flick: Innovator in Solid Oral Dosage Forms

Introduction

Dieter Flick is a notable inventor based in Böhl-Iggelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. His innovative approach has led to advancements in the sustained release of active ingredients, benefiting both manufacturers and patients.

Latest Patents

Dieter Flick holds a patent for a process for producing solid oral dosage forms with sustained release of active ingredients. This invention involves a preformulated mixture of polyvinyl acetate and polyvinylpyrrolidone, along with optional water-soluble polymers or lipophilic additives. The process includes granulating this mixture by heating it to temperatures ranging from 40°C to 130°C, followed by tabletting the granules after admixture with conventional excipients. This patent showcases his expertise in pharmaceutical formulation and innovation.

Career Highlights

Throughout his career, Dieter Flick has worked with prominent companies in the industry, including BASF Aktiengesellschaft and BASF SE Corporation. His experience in these organizations has allowed him to refine his skills and contribute to various projects focused on drug formulation and delivery systems.

Collaborations

Dieter has collaborated with notable colleagues such as Karl Kolter and Hermann Ascherl. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.

Conclusion

Dieter Flick's contributions to the field of solid oral dosage forms have made a lasting impact on pharmaceutical sciences. His innovative processes and collaborations with industry leaders highlight his role as a key figure in advancing drug delivery technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…